Cytokinetics (CYTK) Shares Outstanding: 2009-2025
Historic Shares Outstanding for Cytokinetics (CYTK) over the last 8 years, with Sep 2025 value amounting to $122.1 million.
- Cytokinetics' Shares Outstanding rose 3.59% to $122.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $122.1 million, marking a year-over-year increase of 3.59%. This contributed to the annual value of $118.2 million for FY2024, which is 16.30% up from last year.
- Latest data reveals that Cytokinetics reported Shares Outstanding of $122.1 million as of Q3 2025, which was up 2.10% from $119.6 million recorded in Q2 2025.
- Cytokinetics' 5-year Shares Outstanding high stood at $122.1 million for Q3 2025, and its period low was $71.6 million during Q1 2021.
- Its 3-year average for Shares Outstanding is $109.9 million, with a median of $117.5 million in 2024.
- Data for Cytokinetics' Shares Outstanding shows a peak YoY increased of 22.50% (in 2024) over the last 5 years.
- Over the past 5 years, Cytokinetics' Shares Outstanding (Quarterly) stood at $84.8 million in 2021, then increased by 11.83% to $94.8 million in 2022, then increased by 7.17% to $101.6 million in 2023, then rose by 16.30% to $118.2 million in 2024, then climbed by 3.59% to $122.1 million in 2025.
- Its Shares Outstanding was $122.1 million in Q3 2025, compared to $119.6 million in Q2 2025 and $119.2 million in Q1 2025.